Dipti Amin
Director, Lineage Cell Therapeutics.
Companies
- Lineage Cell TherapeuticsBoard member Apr 22, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lineage Cell Therapeutics LCTX35,000 shares2$34.6K at $0.99Mar 28, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 28, 2022Bought 35,000 shares at $1.63 of Lineage Cell Therapeutics2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2